Clinical Trials

Phase NA Active not recruiting

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT04832763 2026-06-05

Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer

32 enrolled

Colorectal Neoplasms

NCT06307548 2026-06-05

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Phase 1/2 Recruiting

21 enrolled

Colorectal Neoplasms

NCT06420726 2026-06-05

Resistance Exercise and Creatine in Colorectal Cancer

Phase NA Completed

27 enrolled

Colorectal Neoplasms

NCT07071961 2026-06-05

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Phase 2 Suspended

16 enrolled

Colorectal Neoplasms

NCT07618273 2026-06-05

Smart Symptom Tracking ALEX Application for Tracking and Monitoring Gastrointestinal Health, Smart Horizons Pilot Trial

50 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Colorectal Neoplasms

NCT07627191 2026-06-05

GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

30 enrolled

Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07628998 2026-06-05

Impact of SMS Messaging on Participation in Colorectal Cancer Screening.

10,084 enrolled

GastrointestinalGynecologic

Patient Compliance, Patient Participation, Colorectal Neoplasms

NCT01719926 2026-06-04

PIFA

Phase 1 Completed

13 enrolled

Esophageal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02070146 2026-06-04

PLCRC

50,000 enrolled

Phase 2 Active not recruiting

Colorectal Neoplasms

NCT05576896 2026-06-04

Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

7 enrolled

Colorectal Neoplasms

NCT06314022 2026-06-04

PREPCOLON

470 enrolled

Phase NA Enrolling by invitation

Colorectal Neoplasms

NCT06822530 2026-06-04

A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial

682 enrolled

Colorectal Neoplasms

NCT07162337 2026-06-04

BILMOD

40 enrolled

GastrointestinalOther

Obesity, Colorectal Neoplasms

NCT07225309 2026-06-04

A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer

BreastGastrointestinalGenitourinaryHead & Neck

300 enrolled

Breast Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT07403981 2026-06-04

Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

60 enrolled

Colorectal Neoplasms

NCT07569250 2026-06-04

CoSMMO

7,220 enrolled

Colorectal Neoplasms

NCT07611071 2026-06-04

AI-Integrated Emotional Granularity Training for Resilience and Quality of Life in Colorectal Cancer Survivors

54 enrolled

Emotional Regulation, Colorectal Neoplasms

NCT07612436 2026-06-04

AI-empowered Nudge to Improve Colonoscopy Uptake (AINC)

1,680 enrolled

Colorectal Neoplasms

NCT07619859 2026-06-04

Impact of Fusobacterium Nucleatum on Response to Anti-EGFR Therapy in Metastatic Colorectal Cancer

Active not recruiting

Phase 2 Active not recruiting

Colorectal Neoplasms

NCT00492999 2026-06-03

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

64 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT06130826 2026-06-03

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

Phase 1 Suspended

24 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT06192862 2026-06-03

Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake

Phase NA Completed

Colorectal Neoplasms

NCT06559059 2026-06-03

Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs

1,800 enrolled

BreastGastrointestinal

Breast Neoplasms, Disease, Colorectal Neoplasms

NCT07430540 2026-06-03

Optimising Colorectal Cancer Patient Pathways

1,000 enrolled

Phase 2 Not yet recruiting

Colorectal Neoplasms

NCT07622550 2026-06-03

A Single-arm, Multicenter Clinical Study of Fruquintinib Combined With Serplulimab and Chemotherapy as First-line Treatment for Patients With RAS/BRAF-mutated Advanced Colorectal Cance

80 enrolled

Phase 4 Not yet recruiting

Colorectal Neoplasms

NCT07624916 2026-06-03

Transversus Abdominis Plane and Rectus Sheath Block for Robotic Colectomy

90 enrolled

Colorectal Neoplasms

NCT03823144 2026-06-02

Intravital Microscopy in Human Solid Tumors

BreastCNSGastrointestinalSarcoma

85 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT05334069 2026-06-02

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

BreastDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidMyeloidOther hematologic neoplasmSarcomaThoracic

2,000 enrolled

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Esophageal Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05673148 2026-06-02

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Phase 3 Recruiting

364 enrolled

Colorectal Neoplasms

NCT06063928 2026-06-02

Confronting Cancer as a Community

Colorectal Neoplasms

NCT06692959 2026-06-02

Neo-POLEM

Phase 2 Terminated

3 enrolled

GastrointestinalOther neoplasm

Colorectal Neoplasms

NCT07319104 2026-06-02

FECCO-BioBank

Not yet recruiting

1,000 enrolled

Colonic Neoplasms, Lymphatic Metastasis, Precancerous Conditions, Colorectal Neoplasms

NCT07436637 2026-06-02

Guardant Shield Colorectal Cancer Screening

Phase 2 Not yet recruiting

Colorectal Neoplasms

NCT07621497 2026-06-02

FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)

229 enrolled

Colorectal Neoplasms

NCT07621757 2026-06-02

PRO-GENE-COLON

Enrolling by invitation

100 enrolled

Phase 2 Active not recruiting

Colorectal Neoplasms

NCT03935893 2026-06-01

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

20 enrolled

DermatologicEndocrineGastrointestinalNETOther solid neoplasmSarcomaThoracic

Turcot syndrome, Mesothelioma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Neuroendocrine Tumors, Microsatellite Instability

NCT05411718 2026-06-01

A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome

Phase 2 Recruiting

40 enrolled

Phase NA Active not recruiting

Colorectal Neoplasms, Hereditary Nonpolyposis, Colorectal Neoplasms

NCT05720910 2026-06-01

FRONE

720 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT06680739 2026-06-01

SERPENTINE

Phase 2 Recruiting

60 enrolled

GastrointestinalGynecologic

Colorectal Neoplasms, Endometrial Neoplasms

NCT07136077 2026-06-01

A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Phase 2 Recruiting

20 enrolled

Colorectal Neoplasms, Neoplasm, Residual

NCT07203066 2026-06-01

Effects of Oxaliplatin-Induced Peripheral Neuropathy on Hand Function, Grip Strength and Quality of Life in Colorectal Cancer Patients

Completed

103 enrolled

Colorectal Neoplasms

NCT07500298 2026-06-01

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

Phase 1 Recruiting

41 enrolled

Phase 2 Not yet recruiting

Colorectal Neoplasms

NCT07612007 2026-06-01

HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization

80 enrolled

Colorectal Neoplasms

NCT07617610 2026-06-01

PARTACER

30 enrolled

Colorectal Neoplasms

NCT04739072 2026-05-29

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

1,000 enrolled

Colorectal Neoplasms

NCT07413510 2026-05-29

Precision Nursing vs Conventional Care in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial

Phase NA Withdrawn

Temporarily not available

Colorectal Neoplasms

NCT07614048 2026-05-29

Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS

Colorectal Neoplasms

NCT07615036 2026-05-29

AP-NOSES

800 enrolled